INGR 80.04 Ingredion Inc $INGR Hit a 52 week high of 80.34

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 12:53 PM

INGR 80.04 Ingredion Inc $INGR Hit a 52 week high of 80.34 Closing the day 09:42 at 80.04 +0.20 +0.25% With a day low of 79.64 and a total volume of 11,922.

INGR Recent Posts: http://investorshangout.com/Ingredion-Incorpo...NGR-50606/

INGR Ingredion Inc Recent Headline News

INGREDION TO WEBCAST PRESENTATION TO ANALYSTS ON NOVEMBER 18, 2014
Thomson Reuters ONE - Thu Nov 06, 12:29PM CST
WESTCHESTER, Ill., Nov. 6, 2014 - Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will webcast its Analyst Day presentation on Tuesday, November 18, 2014. Ingredion's senior executives will present a business overview, including a review of future growth drivers, financial performance and long-term targets for the Company.
INGR: 80.51 (+0.67)

5 Takeaways From Ingredion's Quarterly Statement
William Bias - at Seeking Alpha - Thu Nov 06, 8:07AM CST

INGR: 80.51 (+0.67)

Ingredion: A Safe Haven With Improving Prospects
Darspal S Mann - at Seeking Alpha - Wed Nov 05, 9:11AM CST

INGR: 80.51 (+0.67)

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated - PENX
PR Newswire - Tue Nov 04, 11:04AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Penford Corporation (NasdaqGM: PENX) ("Penford"

in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Ingredion Incorporated's (INGR) CEO Ilene Gordon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 5:40PM CDT

INGR: 80.51 (+0.67)

Ingredion meets 3Q profit forecasts
Automated Insights - Thu Oct 30, 10:24AM CDT
WESTCHESTER, Ill. (AP) _ Ingredion Inc. (INGR) on Thursday reported third-quarter net income of $118.6 million.
INGR: 80.51 (+0.67)

Ingredion beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:20AM CDT

INGR: 80.51 (+0.67)

INGREDION INCORPORATED REPORTS SOLID THIRD QUARTER 2014 RESULTS
Thomson Reuters ONE - Thu Oct 30, 5:30AM CDT
- Third quarter 2014 EPS rose 45 percent to $1.60 from $1.10 in the third quarter 2013
INGR: 80.51 (+0.67)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.07 (-0.23), HST: 22.62 (-0.11), CRR: 48.07 (-0.01), CAH: 80.80 (+0.14), AMT: 99.78 (-0.17), ACIW: 19.25 (+0.37), GTI: 4.23 (+0.03), IDA: 61.24 (+0.06), CRCM: 8.93 (-0.04), CVRR: 23.00 (-0.12), BGCP: 8.66 (+0.08), GOV: 23.05 (-0.03), DFT: 31.33 (-0.20), APO: 22.91 (+0.28), FIG: 7.58 (-0.03), AMAG: 34.20 (-0.04), HAR: 105.79 (-0.78), AVP: 10.05 (-0.21), EXLS: 28.78 (+0.13), INGR: 80.51 (+0.67), ALU: 3.10 (+0.05), INCY: 68.63 (-2.58), COP: 70.99 (+0.64), GEL: 46.98 (-0.02), COR: 38.35 (-0.06), GTLS: 43.20 (-0.80), BWA: 54.84 (-0.46), CARB: 11.63 (+0.15), GLOP: 23.74 (+0.08), IDCC: 50.73 (+1.06), HEES: 36.91 (-0.27), BCO: 21.50 (+0.25), DST: 100.19 (+0.84), EPD: 37.59 (+0.32), ABMD: 33.31 (-0.17), CEVA: 16.95 (+1.07), BLL: 64.54 (-0.62), GBX: 63.01 (-0.49), GNC: 43.56 (-0.10), CVI: 47.56 (+0.46), ACOR: 33.24 (-0.49), I: 17.85 (+0.02), FCN: 40.98 (-0.11), CRNT: 1.10 (-0.05), DHX: 11.25 (-0.06), BG: 88.60 (-0.15), CME: 85.16 (+0.02), FCH: 10.54 (-0.08), ALLE: 52.07 (-0.05), AUDC: 4.53 (-0.09), APD: 135.23 (-0.30), DBD: 35.19 (+0.01), HGG: 6.12 (-0.04), CBM: 23.15 (-0.21), CNSL: 27.18 (+0.08), ATK: 110.99 (-0.15), ANR: 2.47 (+0.05), CI: 102.19 (-0.52), ABC: 88.71 (-0.37), GG: 19.88 (+0.63)

PENFORD CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Oct 28, 10:55AM CDT
Rigrodsky & Long, P.A.:
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Penford Corporation of Class Action Against the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
GlobeNewswire - Tue Oct 28, 10:29AM CDT
Levi & Korsinsky notifies investors of Penford Corporation ("Penford" or "the Company"

(Nasdaq

ENX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Ingredion Incorporated (NYSE:INGR). A complaint was filed in Colorado federal court.
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
Business Wire - Mon Oct 27, 10:01AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company"

(NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Concerning the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
PR Newswire - Mon Oct 20, 10:05AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company"

(NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Assessing Risk In Equities In The Consumer Staple Sector
Factoids - at Seeking Alpha - Mon Oct 20, 3:04AM CDT

KO: 42.71 (-0.08), MKC: 72.96 (-0.30), CLX: 100.65 (-1.26), CAG: 34.86 (+0.13), HSY: 96.15 (-0.49), INGR: 80.51 (+0.67), KMB: 113.09 (-0.98), HRL: 54.79 (-0.38), SJM: 100.31 (+0.44), PEP: 98.09 (-0.45), K: 64.00 (+0.20), ADM: 51.26 (+0.45), CPB: 43.85 (unch), LANC: 92.85 (-0.36), PG: 88.50 (-0.10), FLO: 18.88 (+0.12), GIS: 51.00 (unch), CL: 67.88 (-0.41)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.43 (-0.44), TTC: 62.26 (-0.47), HST: 22.62 (-0.11), OCR: 69.53 (+0.33), HI: 34.30 (+0.21), MAIN: 32.22 (-0.16), MHLD: 12.73 (-0.01), PRU: 84.13 (-0.40), DEI: 27.81 (-0.07), PSA: 186.40 (-0.64), THG: 69.14 (-0.07), KKR: 22.11 (+0.05), RL: 173.93 (+0.76), VTR: 68.77 (-0.74), AEP: 56.19 (-0.12), EVR: 51.42 (-0.17), TECH: 90.80 (-1.30), ROK: 110.06 (+1.90), INGR: 80.51 (+0.67), WTI: 9.67 (+0.38), COR: 38.35 (-0.06), EXL: 12.89 (-0.08), UG: 20.75 (+0.89), BGS: 28.75 (-0.56), ESV: 38.64 (-0.12), APTS: 8.63 (-0.06), EL: 71.60 (-0.95), HEI: 53.12 (-0.24), GE: 26.45 (+0.03), BOKF: 68.01 (+0.06), SNA: 135.16 (-0.42), BCPC: 65.19 (-0.75), SBUX: 78.23 (+0.34), V: 249.84 (-1.08), KIM: 24.59 (-0.15), BBSI: 22.52 (+0.22), SIX: 40.49 (-0.04), EMCI: 32.00 (-0.34), CHS: 15.43 (+0.04), NEU: 385.06 (+1.37), BMR: 21.52 (-0.20), EMN: 83.90 (+0.33), PRA: 45.32 (-0.03), CBL: 18.77 (-0.15), CUBE: 21.06 (-0.06), DIS: 90.72 (+0.23), BMY: 57.79 (-0.01), ABC: 88.71 (-0.37), RCII: 32.43 (-0.10), WCN: 50.37 (+0.08), HCI: 42.58 (+0.78), MAC: 68.34 (-0.01), AMTD: 34.85 (unch), HUB.B: 111.00 (-0.32), JCI: 49.34 (-0.07)

PENFORD CORPORATION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penford Corporation
PR Newswire - Wed Oct 15, 5:28PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF"

are investigating the proposed sale of Penford Corporation ("Penford" or the "Company"

(NASDAQ: PENX) to Ingredion Incorporated (NYSE: INGR). Under the terms of the proposed transaction, shareholders of Penford will receive only $19 in cash for each share of Penford common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Penford Corporation Stockholders
Business Wire - Wed Oct 15, 4:52PM CDT
Kirby McInerney LLP is investigating potential claims against Penford Corporation ("Penford" or the "Company"

(NASDAQ: PENX) concerning the proposed acquisition of the Company by Ingredion Incorporated ("Ingredion"

(NYSE: INGR). Under the terms of the definitive merger agreement, Penford stockholders will receive $19.00 in cash for each share of Penford common stock they own, valuing the transaction at approximately $340 million.
INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Ingredion: Nice Deal, Nice Appeal!
The Value Investor - at Seeking Alpha - Wed Oct 15, 3:08PM CDT

INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Penford agrees to sale in $340M deal
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 2:38PM CDT

INGR: 80.51 (+0.67), PENX: 18.83 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...